This is in line with observations in adult-onset disease, where CREMα has been established as a key driver of epigenetic dysregulation (including DNA methylation) through its interactions with DNMTs, among others, resulting in silencing of the IL2 gene [31, 103–106], a hallmark of effector T cells in SLE. Here, IL2 is linked to systemic lupus erythematosus.